Literature DB >> 11157194

Calcium ion transients in peri-infarct depolarizations may deteriorate ion homeostasis and expand infarction in focal cerebral ischemia in cats.

K Ohta1, R Graf, G Rosner, W D Heiss.   

Abstract

BACKGROUND AND
PURPOSE: Harmful effects of peri-infarct depolarizations (PIDs) may depend on recurrent Ca(2+) influx. Thus far, few studies have documented the relevance of PIDs in gyrencephalic animals, and the progressive nature of this process has not been investigated over extended periods. We therefore studied in prolonged focal ischemia in cats spatial and temporal profiles of extracellular calcium ([Ca(2+)](o)) shifts in relation to direct current (DC) potential, nitric oxide (NO) concentration and regional cerebral blood flow alterations, and final pathological outcome.
METHODS: In halothane-anesthetized cats receiving either vehicle (n=12) or MK-801 treatment (5 mg/kg IV; n=10), the left middle cerebral artery was permanently occluded. Laser-Doppler probes, ion-selective microelectrodes, and NO electrodes measured simultaneously regional cerebral blood flow, DC potential, electrocorticogram, [Ca(2+)](o), and NO concentrations in ectosylvian and suprasylvian gyri of the left cerebral cortex.
RESULTS: Persistent depolarization immediately after middle cerebral artery occlusion occurred in 10 ectosylvian and 4 suprasylvian gyri of vehicle-treated animals and in 9 ectosylvian and 3 suprasylvian gyri of MK-801-treated animals. PIDs associated with transient decreases of [Ca(2+)](o) were detected in suprasylvian gyri of only 4 vehicle-treated animals, of which 3 developed recurrent PIDs. Electrocorticogram was suppressed during PIDs, and electrocorticogram recovery worsened in a stepwise manner with consecutive depolarizations. PID duration increased slightly with ongoing ischemia and evolved to persistent depolarization at a final stage. NO transients were not detected during PID, and regional cerebral blood flow transients were not pronounced. Infarction was larger with initial persistent depolarization than with PID and was smallest in MK-801-treated animals.
CONCLUSIONS: PID is not a common finding in peri-infarct zones in cats, and it is suppressed by the N:-methyl-D-aspartate antagonist MK-801. However, if repeated PIDs are generated, they result in a stepwise, progressive breakdown of neuronal function and ion homeostasis, probably contributing to the growth of infarction in focal cerebral ischemia. Recurrent Ca(2+) influx is a mechanism that presumably contributes to this process.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11157194     DOI: 10.1161/01.str.32.2.535

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  19 in total

1.  Paradoxical Ca2+ rises induced by low external Ca2+ in rat hippocampal neurones.

Authors:  Andrea Burgo; Giorgio Carmignoto; Paola Pizzo; Tullio Pozzan; Cristina Fasolato
Journal:  J Physiol       Date:  2003-04-11       Impact factor: 5.182

Review 2.  Neuroprotection for ischemic stroke: two decades of success and failure.

Authors:  Yu Dennis Cheng; Lama Al-Khoury; Justin A Zivin
Journal:  NeuroRx       Date:  2004-01

Review 3.  Clinical relevance of cortical spreading depression in neurological disorders: migraine, malignant stroke, subarachnoid and intracranial hemorrhage, and traumatic brain injury.

Authors:  Martin Lauritzen; Jens Peter Dreier; Martin Fabricius; Jed A Hartings; Rudolf Graf; Anthony John Strong
Journal:  J Cereb Blood Flow Metab       Date:  2010-11-03       Impact factor: 6.200

Review 4.  The continuum of spreading depolarizations in acute cortical lesion development: Examining Leão's legacy.

Authors:  Jed A Hartings; C William Shuttleworth; Sergei A Kirov; Cenk Ayata; Jason M Hinzman; Brandon Foreman; R David Andrew; Martyn G Boutelle; K C Brennan; Andrew P Carlson; Markus A Dahlem; Christoph Drenckhahn; Christian Dohmen; Martin Fabricius; Eszter Farkas; Delphine Feuerstein; Rudolf Graf; Raimund Helbok; Martin Lauritzen; Sebastian Major; Ana I Oliveira-Ferreira; Frank Richter; Eric S Rosenthal; Oliver W Sakowitz; Renán Sánchez-Porras; Edgar Santos; Michael Schöll; Anthony J Strong; Anja Urbach; M Brandon Westover; Maren Kl Winkler; Otto W Witte; Johannes Woitzik; Jens P Dreier
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

5.  Advances in stroke therapy.

Authors:  Hayder Jaffer; Viola B Morris; Desiree Stewart; Vinod Labhasetwar
Journal:  Drug Deliv Transl Res       Date:  2011-12-01       Impact factor: 4.617

6.  Is spreading depolarization characterized by an abrupt, massive release of gibbs free energy from the human brain cortex?

Authors:  Jens P Dreier; Thomas Isele; Clemens Reiffurth; Nikolas Offenhauser; Sergei A Kirov; Markus A Dahlem; Oscar Herreras
Journal:  Neuroscientist       Date:  2012-07-24       Impact factor: 7.519

7.  Controversies and evolving new mechanisms in subarachnoid hemorrhage.

Authors:  Sheng Chen; Hua Feng; Prativa Sherchan; Damon Klebe; Gang Zhao; Xiaochuan Sun; Jianmin Zhang; Jiping Tang; John H Zhang
Journal:  Prog Neurobiol       Date:  2013-09-25       Impact factor: 11.685

Review 8.  N-methyl D-aspartate (NMDA) receptor antagonists and memantine treatment for Alzheimer's disease, vascular dementia and Parkinson's disease.

Authors:  David Olivares; Varun K Deshpande; Ying Shi; Debomoy K Lahiri; Nigel H Greig; Jack T Rogers; Xudong Huang
Journal:  Curr Alzheimer Res       Date:  2012-07       Impact factor: 3.498

9.  Cortical spreading depression activates and upregulates MMP-9.

Authors:  Yasemin Gursoy-Ozdemir; Jianhua Qiu; Norihiro Matsuoka; Hayrunnisa Bolay; Daniela Bermpohl; Hongwei Jin; Xiaoying Wang; Gary A Rosenberg; Eng H Lo; Michael A Moskowitz
Journal:  J Clin Invest       Date:  2004-05       Impact factor: 14.808

10.  Simultaneous multispectral reflectance imaging and laser speckle flowmetry of cerebral blood flow and oxygen metabolism in focal cerebral ischemia.

Authors:  Phill B Jones; Hwa Kyoung Shin; David A Boas; Bradley T Hyman; Michael A Moskowitz; Cenk Ayata; Andrew K Dunn
Journal:  J Biomed Opt       Date:  2008 Jul-Aug       Impact factor: 3.170

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.